The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.111.187708PMID 22106100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic Regulation: A Human Perspective

  2011cited by this paper
• TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats

  2011cited by this paper
• Acute stimulation of glucagon secr etion by linoleic acid results from GPR 40 activation and [ Ca 2 C ] i increase in pancreatic islet a-cells

  2011cited by this paper
• Acute stimulation of glucagon secretion by linoleic acid results from GPR40 activation and [Ca2+]i increase in pancreatic islet {alpha}-cells.

  2011cited by this paper
• Glucose Suppression of Glucagon Secretion

  2010cited by this paper
• Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.

  2010cited by this paper
• Membrane Potential-Dependent Inactivation of Voltage-Gated Ion Channels in α-Cells Inhibits Glucagon Secretion From Human Islets

  2010cited by this paper
• GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis.

  2010cited by this paper
• Exocytotic Properties of Human Pancreatic β‐cells

  2009cited by this paper
• Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes

  2009cited by this paper
• G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell.

  2009cited by this paper
• Tight Coupling

  2009influential reference
• Chronic Palmitate Exposure Inhibits Insulin Secretion by Dissociation of Ca2+ Channels from Secretory Granules

  2009cited by this paper
• The Barrier of Hypoglycemia in Diabetes

  2008cited by this paper
• Production and characterization of a monoclonal antibody against GPR40 (FFAR1; free fatty acid receptor 1).

  2008cited by this paper
• Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice

  2008cited by this paper
• An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.

  2008cited by this paper
• Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon

  2008cited by this paper
• Voltage-Gated Ion Channels in Human Pancreatic β-Cells: Electrophysiological Characterization and Role in Insulin Secretion

  2008cited by this paper
• Long-Term Exposure to Glucose and Lipids Inhibits Glucose-Induced Insulin Secretion Downstream of Granule Fusion With Plasma Membrane

  2007cited by this paper
• GPR40 is expressed in glucagon producing cells and affects glucagon secretion.

  2007cited by this paper
• Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.

  2007cited by this paper
• A KATP Channel-Dependent Pathway within α Cells Regulates Glucagon Release from Both Rodent and Human Islets of Langerhans

  2007cited by this paper
• Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells

  2007cited by this paper
• α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains.

  2007cited by this paper
• Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterisation and involvement in insulin secretion

  2007cited by this paper
• Reduction in voltage-gated K+ currents in primary cultured rat pancreatic beta-cells by linoleic acids.

  2006cited by this paper
• Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules

  2006cited by this paper
• Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion

  2006influential reference
• Glucose-sensing mechanisms in pancreatic β-cells

  2005cited by this paper
• Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release.

  2005cited by this paper
• ATP-Sensitive K Channel – Dependent Regulation of Glucagon Release and Electrical Activity by Glucose in Wild-Type and SUR 1 / Mouse-Cells

  2004cited by this paper
• ATP-Sensitive K+ Channel–Dependent Regulation of Glucagon Release and Electrical Activity by Glucose in Wild-Type and SUR1−/− Mouse α-Cells

  2004cited by this paper
• Palmitate increases L‐type Ca2+ currents and the size of the readily releasable granule pool in mouse pancreatic β‐cells

  2004cited by this paper
• Palmitate stimulation of glucagon secretion in mouse pancreatic alpha-cells results from activation of L-type calcium channels and elevation of cytoplasmic calcium.

  2004cited by this paper
• Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40

  2003cited by this paper
• Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes.

  2002cited by this paper
• ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis

  2001cited by this paper
• Tight Coupling Between Electrical Activity and Exocytosis in Mouse Glucagon-Secreting-Cells

  2000cited by this paper
• Regulation of glucagon release in mouse α‐cells by KATP channels and inactivation of TTX‐sensitive Na+ channels

  2000cited by this paper
• Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells.

  2000cited by this paper
• Homologous and heterologous asynchronicity between identified α‐, β‐ and δ‐cells within intact islets of Langerhans in the mouse

  1999cited by this paper
• Homologous and heterologous asynchronicity between identified alpha-, beta- and delta-cells within intact islets of Langerhans in the mouse.

  1999cited by this paper
• Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans.

  1999cited by this paper
• Impact of lack of suppression of glucagon on glucose tolerance in humans.

  1999cited by this paper
• Ca2+ oscillations in pancreatic islet cells secreting glucagon and somatostatin.

  1995cited by this paper
• Progress of discovery

  1993cited by this paper
• Automated Method for Isolation of Human Pancreatic Islets

  1988cited by this paper

• Microcin Y utilizes its stable structure and biological activity to regulate the metabolism of intestinal probiotics and effectively clear gut Salmonella.

  2024cites this paper
• Metabolic and Molecular Amplification of Insulin Secretion.

  2024cites this paper
• Metabolic regulation of glucagon secretion.

  2023cites this paper
• Yiqi Huazhuo decoction increases insulin secretion in type 2 diabetic rats by regulating the pancreatic GPR40-IP3R-1 signaling pathway

  2023cites this paper
• Highly Enantioselective Rhodium-Catalyzed Transfer Hydrogenation of Tetrasubstituted Olefins: Application toward the Synthesis of GPR40 Agonist MK-2305.

  2022cites this paper
• Taste Receptors Function as Nutrient Sensors in Pancreatic Islets: A Potential Therapeutic Target for Diabetes.

  2022cites this paper
• Targeting Islet GPCRs to Improve Insulin Secretion

  2021cites this paper
• Contribution of Mitochondria to Insulin Secretion by Various Secretagogues

  2021cites this paper
• Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges

  2021cites this paper
• Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators

  2021influential citation
• In silico design of bioisosteric modifications of drugs for the treatment of diabetes.

  2021cites this paper
• Non-glucose modulators of insulin secretion in healthy humans: (dis)similarities between islet and in vivo studies.

  2021cites this paper
• Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus

  2021cites this paper
• GPR120 regulates pancreatic polypeptide secretion from male mouse islets via PLC-mediated calcium mobilization.

  2020cites this paper
• Free Fatty Acid Receptors in Health and Disease.

  2020cites this paper
• A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice.

  2020cites this paper
• Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.

  2020cites this paper
• Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites

  2019cites this paper
• Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications

  2019cites this paper
• GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells

  2019cites this paper
• Free Fatty Acid Receptors as new potential therapeutic target in Inflammatory Bowel Diseases.

  2019cites this paper
• Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges

  2018cites this paper
• Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment

  2018cites this paper
• The current state of GPCR‐based drug discovery to treat metabolic disease

  2018cites this paper
• Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men.

  2018cites this paper
• Free fatty acid receptor (FFA) and lipid receptor (GPR119) signalling mediates nutrient-sensing in mouse intestine

  2018cites this paper
• Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience

  2018cites this paper
• Novel tools for molecular imaging and bioconjugation. Synthesis and characterization of new probes and tracers for the visualization of β-Cells

  2018cites this paper
• Identification of novel G-protein-coupled receptor 40 (GPR40) agonists by hybrid in silico-screening techniques and molecular dynamics simulations thereof

  2018cites this paper
• Delphinidin Reduces Glucose Uptake in Mice Jejunal Tissue and Human Intestinal Cells Lines through FFA1/GPR40

  2017cites this paper
• Protective role of Pollen Typhae total flavone against the palmitic acid-induced impairment of glucose-stimulated insulin secretion involving GPR40 signaling in INS-1 cells.

  2017cites this paper
• Syddansk Universitet Complex Pharmacology of Free Fatty Acid Receptors

  2017cites this paper
• Toward molecular imaging of the free fatty acid receptor 1

  2017cites this paper
• Complex Pharmacology of Free Fatty Acid Receptors.

  2017cites this paper
• Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance

  2017cites this paper
• Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion

  2017cites this paper
• GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose production

  2017cites this paper
• Therapeutic molecules against type 2 diabetes: What we have and what are we expecting?

  2017cites this paper
• Combining the G‐protein‐coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12‐week trial

  2017cites this paper
• Retinal energy demands control vascular supply of the retina in development and disease: The role of neuronal lipid and glucose metabolism

  2017cites this paper
• Fasiglifam for glycaemic control in people with type 2 diabetes: A phase III, placebo‐controlled study

  2017cites this paper
• Effects of Free Fatty Acids on Insulin and Glucagon Secretion : – with special emphasis on the role of Free fatty acid receptor 1

  2017cites this paper
• Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators.

  2017cites this paper
• GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy[S]

  2017cites this paper
• GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges.

  2016cites this paper
• Mercaptoacetate blocks fatty acid-induced GLP-1 secretion in male rats by directly antagonizing GPR40 fatty acid receptors.

  2016cites this paper
• G protein-coupled receptors as targets for anti-diabetic therapeutics

  2016cites this paper
• Deletion of GPR40 fatty acid receptor gene in mice blocks mercaptoacetate-induced feeding.

  2016cites this paper
• Ligands at Free Fatty Acid Receptor 1 (GPR40).

  2016cites this paper
• Short report Open Access

  2015cites this paper
• Pancreatic Islet Adaptation and Failure in Obesity and Diabetes

  2015cites this paper
• Mathematical Modeling of Electrical Activity and Exocytosis in Intestinal L-cells and Pancreatic Beta-cells

  2015cites this paper
• Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine

  2015influential citation
• Differential Gene Expression in GPR40-Overexpressing Pancreatic β-cells Treated with Linoleic Acid

  2015cites this paper
• Free fatty acid receptor 1 (FFAR1/GPR40) signaling affects insulin secretion by enhancing mitochondrial respiration during palmitate exposure.

  2015cites this paper
• GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit

  2015cites this paper
• Rosiglitazone inhibition of calvaria-derived osteoblast differentiation is through both of PPARγ and GPR40 and GSK3β-dependent pathway.

  2015cites this paper
• High-Fat Diet-Induced Insulin Resistance Does Not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets

  2015cites this paper
• Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists

  2014cites this paper
• Therapeutic Approaches for Preserving or Restoring Pancreatic β-Cell Function and Mass

  2014cites this paper
• Minimal modeling of insulin secretion in the perfused rat pancreas: a drug effect case study.

  2014cites this paper
• Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Normal or Varying Degrees of Impaired Renal Function

  2014cites this paper
• [Discovery and development of a selective GPR40/FFAR1 agonist, fasiglifam, for treatment of type 2 diabetes mellitus].

  2014cites this paper
• The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism

  2014cites this paper
• Physiology and therapeutics of the free fatty acid receptor GPR40.

  2014cites this paper
• Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice

  2014cites this paper
• A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro

  2014cites this paper
• CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients

  2014cites this paper
• Generating thermostabilized agonist-bound GPR40/FFAR1 using virus-like particles and a label-free binding assay

  2014cites this paper
• G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets

  2014cites this paper
• Something old, something new and something very old: drugs for treating type 2 diabetes

  2014cites this paper
• The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets

  2013cites this paper
• Drugs or diet? – Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs

  2013influential citation
• A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1

  2013cites this paper
• The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?

  2013cites this paper
• TAK‐875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β‐cell dysfunction in Zucker diabetic fatty rats

  2013cites this paper
• [Membrane fatty acid receptors in the β-cell: novel therapeutic targets for type 2 diabetes].

  2013cites this paper
• Regulation of insulin secretion in human pancreatic islets.

  2013cites this paper
• FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.

  2013cites this paper
• Minireview: The Effects of Species Ortholog and SNP Variation on Receptors for Free Fatty Acids

  2013cites this paper
• Modulating GPR40: therapeutic promise and potential in diabetes.

  2013cites this paper
• Free fatty acid receptors and their role in regulation of energy metabolism.

  2013cites this paper
• Reviews of Physiology, Biochemistry and Pharmacology, Vol. 164

  2013cites this paper
• Les récepteurs membranaires des acides gras de la cellule β - De nouvelles cibles thérapeutiques pour le traitement du diabète de type 2 ?

  2013cites this paper
• Free Fatty Acid Receptor 1: A New Drug Target for Type 2 Diabetes?

  2012cites this paper
• Evolving Therapeutic Options for Type 2 Diabetes Mellitus: An Overview

  2012cites this paper
• G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1

  2012cites this paper
• A Multiple‐Ascending‐Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK‐875, in Subjects With Type 2 Diabetes

  2012cites this paper
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK‐875: Results From a Double‐Blind, Placebo‐Controlled Single Oral Dose Rising Study in Healthy Volunteers

  2012cites this paper
• GPR40: a therapeutic target for mediating insulin secretion (review).

  2012cites this paper
• Glucose activates free fatty acid receptor 1 gene transcription via phosphatidylinositol-3-kinase-dependent O-GlcNAcylation of pancreas-duodenum homeobox-1

  2012cites this paper